Acs:180 Results Obtained for Macroprolactinemic Samples Multiplexed Mutagenically Separated Pcr: Simulta- Neous Single-tube Detection of the Factor V R506q (g1691a), the Prothrombin G20210a, and the Methyl- Enetetrahydrofolate Reductase A223v (c677t) Variants

نویسنده

  • Michael N. Fahie-Wilson
چکیده

(range, 250% to 86%) indicates a highly variable, sampledependent response of the ACS:180 assay to macroprolactin. The great disparity of values observed when comparing results from macroprolactinemic samples measured by the Elecsys or the Immulite assay with the results obtained by a low-reading method such as ACS:180 may reflect variation in the structure of macroprolactin. Macroprolactin is most probably not one unique macromolecule but rather a heterogeneous family of PRL-IgG complexes that react differently depending on the type of immunoassay used for PRL determination. In conclusion, our study reinforces the point that PRL assays from different manufacturers give highly variable prolactin results for samples containing macroprolactin (4–8). Our data additionally show that the reactivity of macroprolactin in a PRL immunoassay, be it a low-, medium-, or high-reading method, is not identical for all macroprolactinemic samples. This finding underscores the necessity of a systematic screening strategy for macroprolactin in all samples with increased PRL (4, 5, 10, 11). With the Elecsys PRL assay, PEG precipitation, with a cutoff value of 50%, was an efficient and easy-to-use screening tool for the presence of macroprolactin. Because of the interference of PEG in some commercially available PRL assays, the confirmation of macroprolactinemia may require time-consuming methods, such as centrifugal ultrafiltration (9 ) and GFC. We thank Michael N. Fahie-Wilson, Department of Clinical Chemistry, Southend Hospital, Westcliff-on-Sea, Essex, UK, for expert advice.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Simultaneous determination of methylenetetrahydrofolate reductase C677T and factor V G1691A genotypes by mutagenically separated PCR and multiple-injection capillary electrophoresis.

The C677T mutation of the methylenetetrahydrofolate reductase gene and the G1691A (Leiden) mutation of the factor V gene are established risk factors for thromboembolic disease. We here present an assay for the simultaneous genotyping of these common genetic variants. The assay involves a strategy based on multiplex mutagenically separated PCR performed in a single tube containing six primers. ...

متن کامل

Frequency of factor V Leiden (G1691A) and prothrombin (G20210A) polymorphisms in Population of Kerman Province, Iran

Background & Aims:Thromboembolism is an acute cardiovascular disease that ranges from clinically unimportant to massive embolism. Both acquired and hereditary risk factors contribute to the disease.
We aimed to determine the prevalence of two hereditary predisposing factor of the disease, prothrombin G20210A and factor V Leiden (G1691A) polymorphisms, in Kerman population.<br /...

متن کامل

Factor V Leiden, MTHFR C677T and Prothrombin Gene Mutation G20210A in Iranian Patients with Venous Thrombosis

Background: Factor V Leiden, Prothrombin gene (G20210A) and MTHFR (C677T) polymorphism are the main biomarkers for evaluation of tendency for venous thromboembolism. We aimed to investigate the frequency of mutations in factor V Leiden, Prothrombin G20210A and MTHFR C677T and identify the genetic status for these mutations in patients with venous thrombosis. Methods: This study was carried out...

متن کامل

The Association between Preeclampsia and Defined Polymorphisms in Prothrombin and Coagulation Factor V Genes

Background & Aims: Preeclampsia is one of the complications of pregnancy and a major cause of maternal mortality. Since, hypercoagulation is one of the risk factors, defined polymorphisms of V and II coagulation factors (G1691A and G20210A) may increase the risk of the disease. Methods: This investigation was performed on blood samp...

متن کامل

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION

A. 510(k) Number: k093974 B. Purpose for Submission: New Device C. Measurand: Factor II (FII) (Prothrombin) Factor V (FV) Leiden 5, 10 methylenetetrahydrofolate reductase (MTHFR) D. Type of Test: Qualitative genotyping test for single nucleotide polymorphism detection E. Applicant: Osmetech Molecular Diagnostics F. Proprietary and Established Names: eSensor® Thrombophilia Risk Test eSensor® FII...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2001